Media Coverage

Enveric Biosciences (NASDAQ: ENVB) announced that the United States Patent and Trademark Office issued U.S. Patent No. 11,752,130, titled “Carboxylated Psilocybin Derivatives and Methods of Using,” pertaining to the Company’s…

https://www.benzinga.com/general/biotech/22/04/26693851/exclusive-enveric-offers-investors-rare-exposure-to-both-cannabis-and-psychedelic-industries

https://endpts.com/inside-the-race-to-make-psychedelics-mainstream-medicines/

https://www.benzinga.com/markets/cannabis/22/03/26284541/five-companies-developing-second-generation-psychedelics-for-mental-health

https://psychedelichealth.co.uk/2022/02/21/trial-psychedelic-therapy-cancer-distress/

https://www.benzinga.com/markets/cannabis/22/02/25697576/psilocybin-for-cancer-related-distress-enveric-to-launch-clinical-trial-in-partnership-with-univ

https://edmontonjournal.com/cannabis-health/ucalgary-to-collaborate-on-clinical-trial-assessing-psychedelic-treatments-and-cancer-related-distress

https://finance.yahoo.com/news/enveric-biosciences-files-provisional-patent-214536823.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZW52ZXJpYy5jb20v&guce_referrer_sig=AQAAAIp7hCuGPXC1J-RCbbPJx9NsQx6Vv_FJkaRKGgsvfN6gOH4gXdA-Asvck2OuCViP4Xuk_XgLTMWBu2e4cKprhWS4Yo9pSGsXuXEBVV9JhnthUovjabluWHepMDqRGj14_EPIjnoXICNk8rB_uf_w13TzI_r9DobeVVdjBEjOFbD6